NCT05265351

Brief Summary

The aims of the current study are as follows: i) Investigate the relationships between indices derived from ultrafast ultrasound imaging and Pditw, ii) Investigate the relationships between indices derived from ultrafast ultrasound imaging and diaphragm EMG, iii) Investigate the performance of ultrafast ultrasound for the diagnosis of diaphragm dysfunction, iv) Investigate the ability of ultrafast ultrasound imaging to decipher the cause of diaphragm dysfunction i.e. contractility alteration and/or phrenic nerves conduction defect.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 3, 2022

Completed
1.2 years until next milestone

Study Start

First participant enrolled

May 24, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

1.4 years

First QC Date

February 1, 2022

Last Update Submit

September 26, 2023

Conditions

Keywords

DiaphragmUltrafast ultrasound imagingElectrophysiologyCervical magnetic stimulationElectromyography

Outcome Measures

Primary Outcomes (1)

  • Significant relationship between maximal diaphragm tissue velocity and transdiaphragmatic twitch pressure

    Through study completion, an average of 6 months

Secondary Outcomes (3)

  • Significant relationship between the diaphragm tissue latency and EMG latency

    Through study completion, an average of 6 months

  • Accurate discrimination between patients with or without diaphragm dysfunction using metrics derived from ultrafast ultrasound

    Through study completion, an average of 6 months

  • Accurate discrimination between patients with or without phrenic conduction abnormality using metrics derived from ultrafast ultrasound

    Through study completion, an average of 6 months

Study Arms (1)

Patients with confirmed or suspected diaphragm dysfunction

EXPERIMENTAL

Diaphragm function will be assess. Surface electromyography of the diaphragm will be performed in parallel. The abdominals displacement will be recorded using strain gauge. The intra-thoracic and intra-abdominal pressure will be measured using esophageal and gastric catheter-balloon. Ultrafast ultrasound imaging will be performed during Cervical and bi-lateral anterior magnetic stimulation, and during phrenic electrical stimulation.

Diagnostic Test: Transdiaphragmatic pressure measurementDiagnostic Test: EMG

Interventions

Ultrafast ultrasound imaging of the diaphragm during artificially evoked responses

Also known as: Ultrafast ultrasound imaging
Patients with confirmed or suspected diaphragm dysfunction
EMGDIAGNOSTIC_TEST

Surface electromyography of the diaphragm for phrenic nerve conduction study

Patients with confirmed or suspected diaphragm dysfunction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 18 years old
  • Patients with confirmed diaphragm dysfunction or suspicion
  • Written informed consent
  • Able to comply with all protocol requirements
  • Affiliate or beneficiary of a social security scheme

You may not qualify if:

  • Known allergy to latex
  • Known allergy to Lidocaine or similar product
  • Pacemaker
  • Guardianship/trusteeship
  • Pregnant or nursing women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Département R3S - Hôpital Pitié-Salpêtrière

Paris, 75013, France

RECRUITING

Study Officials

  • Damien BACHASSON, PhD

    Institute ofMyology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Patients with confirmed or suspected diaphragm dysfunction undergoing transdiaphragmatic pressure measurement in response to phrenic neurostimulation as part of their follow-up or diagnostic. During this examination, ultrafast ultrasound imaging will be performed in diaphragm to capture elicited responses to assess the relationship between the variables derived from the ultrasound of the diaphragm and the variables usually measured during the evaluation of the transdiaphragmatic twitch pressure.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2022

First Posted

March 3, 2022

Study Start

May 24, 2023

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

September 28, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations